Wells Fargo Reiterates Equal Weight Rating on Relay Therapeutics (RLAY)
Tweet Send to a Friend
Wells Fargo analyst Eva Fortea Verdejo reiterated an Equal Weight rating and $4.00 price target on Relay Therapeutics (NASDAQ: RLAY).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
